Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy. (Q54570356)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

1 reference

based on heuristic

inferred from title

lip and oral cavity carcinoma

1 reference

based on heuristic

inferred from title

author name string

Vino T Cheriyan

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

Cessal Thomas

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

Prabha Balaram

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

publication date

2 August 2011

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

137

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

10

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

1435-1444

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

https://scigraph.springernature.com/pub.10.1007/s00432-011-1012-2

0 references

TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Signaling defects and functional impairment in T-cells from cervical cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Alterations in T cells of cancer-bearers: whence specificity?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Interleukin-2 therapy of metastatic renal cell carcinoma: update of phase III trials

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Toward gene therapy for human CD3 deficiencies

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: Clinical implications for oral precancerous lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Development of an immunological staging system to prognosticate disease course in malignant cervical neoplasia.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Selection of the T cell repertoire.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1012-2

21 January 2018

Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of Fc receptor-bearing T-lymphocytes (TG and TM) in oral cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms involved in the down-regulation of TCR zeta chain in tumor versus peripheral blood of oral cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural cytotoxicity and serum blocking in malignant cervical neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of immune response in the prognosis of carcinoma of the uterine cervix: can in vitro analysis provide a better framework for more effective management?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor gangliosides inhibit the tumor-specific immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of poor CD3 response in head and neck cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leucocyte adherence inhibition assay (LAI) in cancer of the oral cavity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of CD3zeta message and protein in tumor infiltrating lymphocytes from solid tumor specimens and malignant ascites from patients with ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21809032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-011-1012-2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21809032

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54570356&oldid=1671688872"